These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 10714735)

  • 1. Beta-blocker therapy for heart failure: the evidence is in, now the work begins.
    Califf RM; O'Connor CM
    JAMA; 2000 Mar; 283(10):1335-7. PubMed ID: 10714735
    [No Abstract]   [Full Text] [Related]  

  • 2. Which beta-blocker for heart failure?
    Patel MR; Gattis W
    Am Heart J; 2004 Feb; 147(2):238. PubMed ID: 14760319
    [No Abstract]   [Full Text] [Related]  

  • 3. Metoprolol CR/XL in the treatment of chronic heart failure.
    Gattis WA
    Pharmacotherapy; 2001 May; 21(5):604-13. PubMed ID: 11349749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Metoprolol CR/XL: advanced formulation of a classical beta-blocker].
    Kobalava ZhD; Gudkov KM
    Kardiologiia; 2003; 43(9):91-100. PubMed ID: 14593374
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metoprolol CR/XL in black patients with heart failure (from the Metoprolol CR/XL randomized intervention trial in chronic heart failure).
    Goldstein S; Deedwania P; Gottlieb S; Wikstrand J;
    Am J Cardiol; 2003 Aug; 92(4):478-80. PubMed ID: 12914886
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of beta-blocker therapy on left atrial function in patients with heart failure: comparison of metoprolol succinate with carvedilol.
    Arslan S; Erol MK; Bozkurt E; Acikel M; Gundogdu F; Atesal S; Senocak H
    Int J Cardiovasc Imaging; 2007 Oct; 23(5):549-55. PubMed ID: 17171429
    [TBL] [Abstract][Full Text] [Related]  

  • 7. What resting heart rate should one aim for when treating patients with heart failure with a beta-blocker? Experiences from the Metoprolol Controlled Release/Extended Release Randomized Intervention Trial in Chronic Heart Failure (MERIT-HF).
    Gullestad L; Wikstrand J; Deedwania P; Hjalmarson A; Egstrup K; Elkayam U; Gottlieb S; Rashkow A; Wedel H; Bermann G; Kjekshus J;
    J Am Coll Cardiol; 2005 Jan; 45(2):252-9. PubMed ID: 15653024
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences between beta-blockers in patients with chronic heart failure and chronic obstructive pulmonary disease: a randomized crossover trial.
    Jabbour A; Macdonald PS; Keogh AM; Kotlyar E; Mellemkjaer S; Coleman CF; Elsik M; Krum H; Hayward CS
    J Am Coll Cardiol; 2010 Apr; 55(17):1780-7. PubMed ID: 20413026
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Does the use of metoprolol-succinate in patients with chronic heart failure lead to a higher efficacy in treatment without causing additional costs?].
    Sonntag F; Schöffski O; Hass B
    MMW Fortschr Med; 2005 Jun; 147(24):39. PubMed ID: 16001533
    [No Abstract]   [Full Text] [Related]  

  • 10. COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Wikstrand J; Fagerberg B; Goldstein S; Kjekshus J; Wedel H
    Lancet; 2003 Sep; 362(9389):1076-7; author reply 1077-8. PubMed ID: 14522542
    [No Abstract]   [Full Text] [Related]  

  • 11. COMET: a proposed mechanism of action to explain the results and concerns about dose.
    Hjalmarson A; Waagstein F
    Lancet; 2003 Sep; 362(9389):1077; author reply 1077-8. PubMed ID: 14522544
    [No Abstract]   [Full Text] [Related]  

  • 12. Nonselective versus selective beta-blockers in the management of chronic heart failure: clinical implications of the carvedilol or Metoprolol European Trial.
    Greenberg B
    Rev Cardiovasc Med; 2004; 5 Suppl 1():S10-7. PubMed ID: 15184835
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy, safety and tolerability of metoprolol CR/XL in patients with diabetes and chronic heart failure: experiences from MERIT-HF.
    Deedwania PC; Giles TD; Klibaner M; Ghali JK; Herlitz J; Hildebrandt P; Kjekshus J; Spinar J; Vitovec J; Stanbrook H; Wikstrand J;
    Am Heart J; 2005 Jan; 149(1):159-67. PubMed ID: 15660048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomized Intervention Trial in Congestive Heart Failure (MERIT-HF).
    Gottlieb SS; Fisher ML; Kjekshus J; Deedwania P; Gullestad L; Vitovec J; Wikstrand J;
    Circulation; 2002 Mar; 105(10):1182-8. PubMed ID: 11889011
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and pharmacodynamics of beta blockers in heart failure.
    Talbert RL
    Heart Fail Rev; 2004 Apr; 9(2):131-7. PubMed ID: 15516861
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The use of metoprolol CR/XL in the treatment of patients with diabetes and chronic heart failure.
    De Freitas O; Lenz O; Fornoni A; Materson BJ
    Vasc Health Risk Manag; 2006; 2(2):139-44. PubMed ID: 17319457
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effects of controlled-release metoprolol on total mortality, hospitalizations, and well-being in patients with heart failure: the Metoprolol CR/XL Randomized Intervention Trial in congestive heart failure (MERIT-HF). MERIT-HF Study Group.
    Hjalmarson A; Goldstein S; Fagerberg B; Wedel H; Waagstein F; Kjekshus J; Wikstrand J; El Allaf D; Vítovec J; Aldershvile J; Halinen M; Dietz R; Neuhaus KL; Jánosi A; Thorgeirsson G; Dunselman PH; Gullestad L; Kuch J; Herlitz J; Rickenbacher P; Ball S; Gottlieb S; Deedwania P
    JAMA; 2000 Mar; 283(10):1295-302. PubMed ID: 10714728
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Commentary on the Carvedilol or Metoprolol European Trial (COMET).
    Poole-Wilson PA
    Am J Cardiol; 2004 May; 93(9A):40B-2B. PubMed ID: 15144936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative study in heart failure. Which beta blocker saves more life time?].
    MMW Fortschr Med; 2003 Oct; 145(40):52. PubMed ID: 14603606
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.